The role of neuroimaging
in dementia of the
working age
Nick Fox Dementia Research Centre
Institute of Neurology, UCL
Queen Square, London
Overview
• Changing role of imaging
• “Working age” dementia
• Guidelines and consensus criteria
• Imaging features of the dementias
• What a scan can tell you – adding value
• A practical approach …
…..and a look to the future
Early-onset dementia. Jefferies & Agrawal APT 2009;15:380-388
The diagnosis of young-onset dementia. Rossor, Fox et al Lancet Neurology 2010;9:793-806.
Changing roles of imaging
• From excluding treatable causes
– Neoplasm, hydrocephalus, subdural
– “Yield” – 1% ?
• To making a positive diagnosis
– moving from “dementia” to a specific diagnosis
• Supporting an earlier diagnosis
– adding specificity to “MCI”
• Adding molecular information
• Research and Trials
Improving diagnosis
• National priority: “Dementia Strategy”
• Patient and carers: Alzheimer’s Society
“…it is crucial to highlight the value of
early diagnosis and intervention …”
Structural imaging for diagnosis
•Structural imaging should be used to assist in the diagnosis of dementia, to aid in the differentiation of type of dementia and to exclude other cerebral pathology
•Magnetic resonance imaging (MRI) is the preferred modality to assist with early diagnosis and detect subcortical vascular changes, although computed tomography (CT) scanning could be used
• CT and MRI may be used to exclude treatable causes of dementia.
• Multislice CT and coronal MRI may be used to assess hippocampal atrophy to support a clinical diagnosis of AD (Level B).
• FDG PET and perfusion SPECT are useful adjuncts when diagnosis remains in doubt (level B).
• Dopaminergic SPECT is useful to differentiate AD from DLB (level A).
• Follow up with serial MRI is useful in a clinical setting to document disease progression (good practice point).
Establishing the subtype diagnosis
• Diagnosis is based on clinical criteria
Imaging supportive but not required
• Alzheimer’s disease
• Dementia with Lewy bodies
• Frontotemporal dementia
• CJD
Imaging needed for vascular dementia
• Extent
• Topography
• Severity
Working age dementia in
the UK
• 40,000 cases (20-60K) vs 700,000 total
• Unusual causes relatively more common –
not so dominated by AD and VaD
• And so are atypical presentations of AD
• Higher proportion of
– “treatable” causes
– Genetic causes
• Some characteristic imaging features
Working age dementia
• AD 30-35%
• Vascular 10-15%
• FTD ~10-15%
• Alcohol ~10%
• DLB ~5%
• Other ~20-25%
• Other .. – HD
– PSP, CBD
– Head injury
– MS
– Epilepsy
– CJD
– Familial AD & trisomy 21
– Antibody mediated
Unusual & “treatable” causes are more common
in younger than older onset dementia
Early-onset dementia. Jefferies, and Agrawal APT 2009;15:380-388
©2009 by The Royal College of Psychiatrists
Changing roles of imaging
• From excluding treatable causes
• To making a positive diagnosis
– moving from “dementia” to a specific diagnosis
“No space occupying lesion. There
is involutional change likely related
to ageing and there are some
scattered white matter
hyperintensities…”
A scan is only as useful as its
interpretation …
What can you ask (look for)
beyond a surgical cause?
• Is the scan normal for age?
• Signal change?
– VaD?
• Look at basal ganglia & brain stem
• Extent of white matter change
– Other?
• Atrophy?
– Is there focal (lobar) or generalised atrophy?
– Disproportionate hippocampal atrophy?
Vascular dementia
• Stepwise progression of dementia may be a feature
but… many cases of VaD have gradual deterioration
• Focal neurological signs (e.g. aphasia, hemiparesis)
may be present but are often not
• Frontal subcortical cognitive profile with gait
abnormalities, brisk reflexes, pout
• Small vessel disease may mimic AD/DLB - insidious
onset and progression including “memory”
1 = Punctate 2 = Early Confluent 3 = Confluent
NEVER normal “Normal” Abnormal < 70
White matter lesions – Fazekas scale
In AD tangles first appear in
Entorhinal Cortex and then
Hippocampus
Transentorhinal
Stages I-II
Limbic
Stages III-IV
Braak & Braak 1991
AD
• Symmetrical atrophy with posterior
greater than anterior loss (cf FTLD)
• The medial temporal lobe and posterior
cingulate are sites of early change
In “mild” AD the hippocampus is
10-20% smaller than in controls
Seab ’88, De Leon ’89, Scheltens ’92, Soininen ’94, Jack ’99, Du ’01, Killiany ’02
MMSE ~20/30
H/c 25% down
Sens & spec ~85%
Less sensitive in younger and milder patients
Arch Neurol 2007
Spiral CT – now able to get
high resolution - atrophy
pattern similar to MRI
Wattjes M P et al. Radiology 2009
MRI CT
Symmetrical hippocampal atrophy is
characteristic of AD but also seen in
Dementia with Lewy Bodies
DLB AD PM proven
Low dopamine transporter uptake in
basal ganglia
AD DLB/PDD
Control PD
A “suggestive
feature” in
consensus criteria
for DLB (2005)
McKeith et al, 2005
O’Brien et al, 2004
Walker et al, 2002-8
FTD patterns…
• Behavioural variant FTD:
– Orbitofrontal or dorsolateral atrophy
• Changes in personality and social behaviour
– Right temporal (+frontal)
• Semantic dementia (svPPA):
– Ant>post; fusiform, pole
• Left: anomia, impaired comprehension & loss of word knowledge
• Right: behaviour
• Progressive nonfluent aphasia:
– Perisylvian – inf frontal
• Disrupted speech output, phonological deficits
• Cf Logopenic aphasia (AD)
Control
AD
FTLD
Jagust et al, Neurology 2007
Functional imaging: metabolic
patterns differ between diseases
FDG-PET
Research? Or the future of
clinical practice?
- an increasing range of
imaging modalities are
available
Structural imaging now can be accelerated –
retaining resolution and contrast
PM-proven AD: 1.5T MRI
Imaging amyloid with PET
PIB: Klunk Ann Neurol ’04; FDDNP: Barrio ’99; F-BAY: Rowe
Lancet Neurol ’08;
[11C] PIB, [18F] FDDNP, [18F] BAY94, [18F] AV 45 & others
MCI non-converter MCI subject who
subsequently
converted to AD
Amyloid binding increases several
years before clinical AD
David Brooks, Hilary Archer, Aren Okello
Maruyama et al.
Neuron 2013
Tau-PET imaging with 11C-PBB3
In vitro binding to
Neurofibrillary tangles, neuropil threads and neurites in AD
Slattery CF et al Phenotypical variation in AD: insights from posterior cortical atrophy. Pract
Neurol 2014.
Profiles of atrophy, glucose metabolism and amyloid deposition in a patient with atypical AD
Ossenkoppele R, et al Annals of Neurology 2014
Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy.
Profiles of atrophy, glucose metabolism and tau deposition in a patient with atypical AD
In practice
• All patients should have structural imaging –
in working age dementia this should be MRI
• Positive predictive value for AD of
hippocampal atrophy – and
posterior>anterior gradient
• Focal atrophy syndromes and heavy
vascular burden suggest non-AD diagnoses
• Consider diffusion imaging in rapid dementia
Conclusion
• Imaging in dementia of working age is an essential part of
diagnosis
– NICE guideline
– Diagnostic criteria for AD, vascular dementia and other dementias
• Only as good as the assessment – a structured approach
can be usefully applied by a non-radiologist
• Positive contribution to the diagnosis of dementia is
possible with imaging and is even more relevant in working
age dementia
Thank you